Abstract :

Background: Dyslipidemia is one of the most common metabolic syndrome among diabetic patients due to several factors include insulin insufficiency, resistance, and central obesity. Furthermore both vitamin D deficiency and diabetes are most public health worldwide problems. Therefore the aim of the present work to study the dyslipidemia and vitamin D status in diabetes patients and also to study the relation between vitamin D status and lipid profile in diabetic patients.
Methods: A Cross sectional study conducted on randomly selected diabetic patients whether have vitamin D deficiency with dyslipidemia, vitamin D deficiency with no dyslipidemia or dyslipidemia with no vitamin D deficiency. A total sample 165 patients enrolled in the study with serum lipid profile, vitamin D and glycemic control measured at beginning and end of the study. The data analysis was done through Chi-square or T test at α< 0.05. Result: The data collected on 165 patients revealed that, patients aged 41-60 years were most common, and female gender was twice as male. This study include both types of diabetes with vitamin D deficiency and dyslipidemia or vitamin D deficiency with no dyslipidemia or dyslipidemia with not vitamin D deficiency as control. Therefore, the result of this work confirmed that vitamin D deficiency significant implicated in elevated serum levels of TG, TC, LDL, VLDL, FPG and HbA1C (P< 0.05). However, vitamin D deficiency has linked to slight increased serum HDL levels. In compared to man, vitamin D deficiency linked significantly to dyslipidemia and abnormal high levels blood glucose and HbA1C par in women. Conclusion: The present study revealed that, vitamin D deficiency associated negatively with serum levels of TC, TG, VLDL, LDL, FPG and HbA1C whereas the deficiency of vitamin D linked to elevated HDL levels. In gender distribution lower vitamin D values associated with elevated serum FPG, HbA1C, lipid profile with exception HDL in women. The data of this study suggested that, diabetic patients with dyslipidemia may improve their lipid profile and glucose hemostasis through vitamin D supplementation

---

Keywords :

Deficiency; Dyslipidemia; FPG; Hba1c; Lipid Profile; Vitamin D.

---

References :

1. Mehta RK, Koirala P, Mallick RL, Parajuli S, Jha R. Dyslipidemia in Patients with Type 2 Diabetes Mellitus in a Tertiary Care Centre: A Descriptive Cross-sectional Study. JNMA J Nepal Med Assoc. 2021;59(236):305-309.
2. Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr. 2004;79(3):362-71.
3. Mashahit M, Elsayed A, Eltoukhy H. Influence of vitamin D level on diabetic dyslipidemia. Asian Journal of Medicine and Health. 2017 Sep 23:1-1.
4. Griz LH, Bandeira F, Gabbay MA, Dib SA, Carvalho EF. Vitamin D and diabetes mellitus: an update 2013. Arquivos Brasileiros de Endocrinologia & Metabologia. 2014;58:1-8.
5. Kayaniyil S, Retnakaran R, Harris S, Vieth R, Knight JA, Gerstein HC, et al. Prospective associations of vitamin D with β-cell function and glycemia: the PROspective Metabolism and ISlet cell Evaluation (PROMISE) cohort study. Diabetes. 2011;60(11):2947-53.
6. Kayaniyil S, Vieth R, Retnakaran R, Knight JA, Qi Y, Gerstein HC, et al. Association of vitamin D with insulin resistance and beta-cell dysfuntion in subjects at risk for type 2 diabetes. Diabetes Care. 2010;33(6):1379-81.
7. Imga NN, Karci AC, Oztas D, Berker D, Guler S. Effects of vitamin D supplementation on insulin resistance and dyslipidemia in overweight and obese premenopausal women. Arch Med Sci. 2019;15(3):598.
8. 8. Karhapää P, Pihlajamäki J, Pörsti I, Kastarinen M, Mustonen J, Niemelä O, et al. Diverse associations of 25-hydroxyvitamin D and 1,25-dihydroxy-vitamin D with dyslipidaemias. J Intern Med. 2010;268(6):604–10
9. Lupton JR, Faridi KF, Martin SS, et al. Deficient serum 25-hydroxyvitamin D is associated with an atherogenic lipid profile: the Very Large Database of Lipids (VLDL-3) study. J Clin Lipidol. 2016;10(1):72–81.
10. Jorde R, Figenschau Y, Hutchinson M, Emaus N, Grimnes G. High serum 25-hydroxyvitamin D concentrations are associated with a favorable serum lipid profile. Eur J Clin Nutr. 2010;64(12):1457.
11. Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ. Baseline serum 25-hydroxyvitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes. 2008;57(10):2619-25.
12. 12. Maestro B, Campion J, Davila N, et al. Stimulation by 1, 25- dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U937 human promonocytic cells. Endocr J. 2003;47:383–391
13. 13. Luong K, Nguyen LT, Nguyen DN. The role of vitamin D in protecting type 1 diabetes mellitus. Diabetes Metab Res Rev. 2005; 21(4):338–46.
14. Wang H, Xia N, Yang Y, Peng D-Q. Influence of vitamin D supplementation on plasma lipid profiles: a meta-analysis of randomized controlled trials. Lipids Health Dis. 2012;11(1):42.
15. Jiang X, Peng M, Chen S, Wu S, Zhang W. Vitamin D deficiency is associated with dyslipidemia: a cross-sectional study in 3788 subjects. Curr Med Res Opin. 2019;35(6):1059-1063.
16. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–1930.
17. Yang K, Liu J, Fu S, Tang X, Ma L, Sun W, Niu Y, Jing G, Niu Q. Vitamin D Status and Correlation with Glucose and Lipid Metabolism in Gansu Province, China. Diabetes Metab Syndr Obes. 2020;13:1555-1563
18. Yan X, Thomson JS, Zhao R, et al. Vitamin D Status of Residents in Taiyuan, China and Influencing Factors. Nutrients. 2017;9(8):898.
19. Souza WN, Aparicio-Ugarriza R, Bibiloni MM, et al. Better body composition and lipid profile can be associated with vitamin D status in Spanish elderly? The PHYSMED study. J Nutr Health Aging. 2017;21(10):1329–1336.
20. Yin X, Sun Q, Zhang X, et al. Serum 25(OH)D is inversely associated with metabolic syndrome risk profile among urban middle-aged Chinese population. Nutr J. 2012;11:68.
21. Jiang X, Peng M, Chen S, Wu S, Zhang W. Vitamin D deficiency is associated with dyslipidemia: a cross-sectional study in 3,788 subjects. Curr Med Res Opin. 2019;35(6):1059–1063.
22. Lu L, Yu Z, Pan A, et al. Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care. 2009;32(7):1278–1283.
23. Szternel L, Krintus M, Bergmann K, Derezinski T, Sypniewska G. Association between fasting glucose concentration, lipid profile and 25(OH)D status in children aged 9(-)11. Nutrients. 2018;10(10):1359.
24. Almaghrbi A, Altarrani M, Elmighrabi N, Bakoush HM, Elmabsout AA. Effect of Vitamin D Supplementation on Blood Glucose Homeostasis, BMI and Lipid Profile in Diabetic Patients with Vitamin D Deficiency. Asian Journal of Basic Science & Research. 2021;3(3):25-35.
25. Yousefi Rad E, Djalali M, Koohdani F, Saboor-Yaraghi AA, Eshraghian MR, Javanbakht MH, Saboori S, Zarei M, Hosseinzadeh-Attar MJ. The Effects of Vitamin D Supplementation on Glucose Control and Insulin Resistance in Patients with Diabetes Type 2: A Randomized Clinical Trial Study. Iran J Public Health. 2014;43(12):1651-6.
26. Quaiz AM, Kazi A, Youssef RM, Alshehri N, Alduraywish SA. Association between standardized vitamin 25(OH)D and dyslipidemia: a community-based study in Riyadh, Saudi Arabia. Environ Health Prev Med. 2020;25(1):4.
27. Chaudhuri JR, Mridula KR, Anamika A, Boddu DB, Misra PK, Lingaiah A, Balaraju B, Bandaru VS. Deficiency of 25-hydroxyvitamin d and dyslipidemia in Indian subjects. Journal of lipids. 2013 Dec 18;2013.
28. AlQuaiz AM, Kazi A, Youssef RM, Alshehri N, Alduraywish SA. Association between standardized vitamin 25 (OH) D and dyslipidemia: a community-based study in Riyadh, Saudi Arabia. Environmental health and preventive medicine. 2020;25(1):1-9.